TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
KLRA

Kailera Therapeutics, Inc.

Healthcare · Biotechnology

10.00$ -5.0% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow KLRA
Line item Q1 25 Q2 25 Q1 26 Q2 26
– – – –
– -1.6% +62.9% +0.0%
– +7.1% +141.5% +111.8%
– – +455.1% +257.9%
– – – –
– – – -2,599.1%
– – -103.0% –
– – – –
– – – –

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?